Skip to main content
Retrospective study(2016-2019) of referred newly, suspected (#RA) pts found no value in initial Xrays. Only 32/724 patie

Dr. John Cush RheumNow

2 years 9 months ago
Retrospective study(2016-2019) of referred newly, suspected (#RA) pts found no value in initial Xrays. Only 32/724 patients (4.4%) had RA like erosions, with Erosions leading to a Dx in only 2 pts (0.3%) & changed prognostic classification in 3 pts (0.4%) https://t.co/fi48WiBgIc https://t.co/skObArXYr6
Orthopedic cohort study of 274,403 pts (180K females, 94K males; mean age=55). The risk of future TKA was signif greater

Dr. John Cush RheumNow

2 years 9 months ago
Orthopedic cohort study of 274,403 pts (180K females, 94K males; mean age=55). The risk of future TKA was signif greater in pts w/ combination of Depression+Obesity group (11.9%); compared to Controls (8.3%), obese (10.2%) or Depression (7.8%) https://t.co/dltVS0Y6PY https://t.co/REgO5tjEUv
ACR QD Clinic - Hemoptysis
Dr. Jack Cush reviews this past week's news on RheumNow.com and suggests a learning plan for those wanting to consume the upcoming ACR Convergence 2023 meeting. 
Research work from the Accelerating Medicines Partnership (AMP: RA/SLE) Network, was published in Nature and more specifically characterizes RA synovium into several cell-type abundance phenotypes (CTAPs). Could CTAPs known disease features or more effective future therapies? 
A recent CDC reports estimates that in 2019–2021, 21% of U.S. adults (53.2 million) have physician diagnosed arthritis. Now, an updated report shows a larger number (~33%) of U.S. veterans having diagnosed arthritis. Compared to nonveterans, this prevalence was double in men, and 60% higher in women.
Introducing RheumNow's #ACR23 faculty! They'll be covering ACR this weekend with valuable tweets, articles, videos and

Dr. John Cush RheumNow

2 years 9 months ago
Introducing RheumNow's #ACR23 faculty! They'll be covering ACR this weekend with valuable tweets, articles, videos and more. Follow us for real time updates. https://t.co/c9jla43lqw
QD Clinics - Neighbor Consults

Your neighbor has a Swollen RPIP4.

QD Clinics are sponsored by RheumNows Coverage of #

Dr. John Cush RheumNow

2 years 9 months ago
QD Clinics - Neighbor Consults Your neighbor has a Swollen RPIP4. QD Clinics are sponsored by RheumNows Coverage of #ACR23 live from San Diego https://t.co/ZXNalfiVFv https://t.co/TAxpVyowF5
Patients Don't Read Textbooks

RA patient unresponsive to biologics, now has enthesitis; what to do?

QD Clinics are sp

Dr. John Cush RheumNow

2 years 9 months ago
Patients Don't Read Textbooks RA patient unresponsive to biologics, now has enthesitis; what to do? QD Clinics are sponsored by RheumNows Coverage of #ACR23 live from San Diego https://t.co/hlacYXm0Nh https://t.co/52Xy3E8kXi
The American College of Rheumatology's (ACR) has published a preview of new research from ACR Convergence 2023 showing that AI and a deep learning system could accurately identify and predict joint space narrowing and erosions in hand radiographs of patients with rheumatoid arthritis (RA).
Routine hand and foot radiographs in more than 700 patients being evaluated for rheumatoid arthritis (RA) made almost no difference in diagnosing the condition nor in predicting its course, Dutch researchers said.
ACR Reacts to 2024 Medicare Physician Fee Schedule

The ACR expressed concern that the conversion factor included in th

Dr. John Cush RheumNow

2 years 9 months ago
ACR Reacts to 2024 Medicare Physician Fee Schedule The ACR expressed concern that the conversion factor included in the CMS CY 2024 Medicare Physician Fee Schedule and Quality Payment Program final rule is insufficient to address rising inflation https://t.co/ZkMdqJEOkm https://t.co/70SxSGckGf
Anakinra Effective in Systemic JIA, Irrespective of HLA-DRB1 and IL1RN Variants

A prospective study of first line use

Dr. John Cush RheumNow

2 years 9 months ago
Anakinra Effective in Systemic JIA, Irrespective of HLA-DRB1 and IL1RN Variants A prospective study of first line use anakinra in systemic juvenile idiopathic arthritis (sJIA) proved to be effective and without potentially allergic lung reactions. https://t.co/MRFwrCXIlQ https://t.co/Su3nMs4CNW
×